Clinical Trial

The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study

Study acronym: SAVVE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, non blinded, single arm, multicenter study designed to assess the safety and effectiveness of the bioprosthetic, VenoValve, which is surgically implanted into the deep venous system for treatment of patients with deep venous valvular insufficiency ( C4b-C6 patients).
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2021-06-21; most recent amendment 2025-02-13.
Status change: Recruiting → Active, Not Recruiting 2025-02-13
Status change: Not Yet Recruiting → Recruiting 2021-10-19
Status change: Withheld → Not Yet Recruiting 2021-07-07
Trial Details
NCT Number NCT04943172
Lead Sponsor Hancock Jaffe Laboratiores, Inc
Collaborators: AXIOM Real Time Metrics, Syntactx
Conditions Deep Venous Insufficiency (Diagnosis)
Enrollment 75 participants
Start Date 2021-08-27
Primary Completion 2024-10-18 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2025-02-17